ELLXF (Elixinol Wellness) PB Ratio: 0.60 (As of Jun. 26, 2026) — Near Median


What is Elixinol Wellness PB Ratio?

Elixinol Wellness ELLXF -0.03% PB Ratio is 0.60 as of Jun. 26, 2026, which is 5% below its 10-year median of 0.63. The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Elixinol Wellness ranks better than 95.66% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Elixinol Wellness's share price is $0.00717. Elixinol Wellness's Book Value per Share for the quarter that ended in Dec. 2025 was $0.01. Hence, Elixinol Wellness's PB Ratio of today is 0.60.

The historical rank and industry rank for Elixinol Wellness's PB Ratio or its related term are showing as below:

ELLXF' s PB Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.63   Max: 4.59
Current: 0.72

During the past 8 years, Elixinol Wellness's highest PB Ratio was 4.59. The lowest was 0.20. And the median was 0.63.

ELLXF's PB Ratio is ranked better than
95.66% of 922 companies
in the Drug Manufacturers industry
Industry Median: 1.825 vs ELLXF: 0.72

During the past 12 months, Elixinol Wellness's average Book Value Per Share Growth Rate was -60.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -53.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -52.10% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Elixinol Wellness was -50.70% per year. The lowest was -65.40% per year. And the median was -55.10% per year.

Back to Basics: PB Ratio


Elixinol Wellness  (OTCPK:ELLXF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Elixinol Wellness PB Ratio Related Terms


Elixinol Wellness PB Ratio Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness PB Ratio Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial 1.59 0.83 1.60 0.65 0.73

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 0.53 0.65 0.41 0.73

ELLXF vs ZTS, UTHR, VTRS: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's PB Ratio distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's PB Ratio falls into.



Elixinol Wellness PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Elixinol Wellness's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.00717/0.012
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.60 mean?
Elixinol Wellness (ELLXF) has a PB Ratio of 0.60 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elixinol Wellness and its competitors. This is near median its historical median of 0.63. Over the past decade, Elixinol Wellness' PB Ratio has ranged from 0.20 to 4.59. According to the industry distribution chart, Elixinol Wellness ranks #40 out of 922 companies in the Drug Manufacturers industry, placing it in the top 4.3%.
Is Elixinol Wellness' PB Ratio too high?
Elixinol Wellness' current PB Ratio of 0.60 is near median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 4.59. The Drug Manufacturers industry median PB Ratio is 1.83. Elixinol Wellness' value of 0.60 is 67.1% below this industry median. Based on the distribution chart, Elixinol Wellness ranks #40 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Elixinol Wellness' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Elixinol Wellness ranks #40 out of 922 companies for PB Ratio. This places Elixinol Wellness in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.83. Elixinol Wellness' value of 0.60 is 67.1% below this benchmark. Historically, Elixinol Wellness' own PB Ratio has ranged from 0.20 to 4.59 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 1.83, Elixinol Wellness has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elixinol Wellness's current PB Ratio of 0.60 is 67.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elixinol Wellness and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elixinol Wellness's current PB Ratio is 0.60, which is near median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ELLXF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.02, compared to a current price of $0.01 — trading 64.2% below its estimated fair value. The current PB Ratio is 0.60, which is near median its 10-year median of 0.63 and 67.1% below the Drug Manufacturers industry median of 1.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Elixinol Wellness (ELLXF), the current PB Ratio is 0.60 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges E8M:GermanyEXL:Australia
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.